Bank of New York Mellon’s Aralez Pharmaceuticals Inc. ARLZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-51,690
| Closed | -$19K | – | 4313 |
|
|
2018
Q2 | $19K | Sell |
51,690
-632
| -1% | -$232 | ﹤0.01% | 4169 |
|
|
2018
Q1 | $79K | Sell |
52,322
-8,250
| -14% | -$12.5K | ﹤0.01% | 4088 |
|
|
2017
Q4 | $86K | Buy |
60,572
+6,162
| +11% | +$8.75K | ﹤0.01% | 4111 |
|
|
2017
Q3 | $125K | Buy |
54,410
+2,769
| +5% | +$6.36K | ﹤0.01% | 3971 |
|
|
2017
Q2 | $71K | Sell |
51,641
-756
| -1% | -$1.04K | ﹤0.01% | 4086 |
|
|
2017
Q1 | $112K | Sell |
52,397
-28,676
| -35% | -$61.3K | ﹤0.01% | 4001 |
|
|
2016
Q4 | $358K | Sell |
81,073
-2,004
| -2% | -$8.85K | ﹤0.01% | 3718 |
|
|
2016
Q3 | $402K | Buy |
83,077
+300
| +0.4% | +$1.45K | ﹤0.01% | 3636 |
|
|
2016
Q2 | $274K | Sell |
82,777
-112,592
| -58% | -$373K | ﹤0.01% | 3781 |
|
|
2016
Q1 | $694K | Buy |
+195,369
| New | +$694K | ﹤0.01% | 3273 |
|